A. Short term problems / considerations b. Long term mission View of human subjects protection system: SACHRP July 2008 Elizabeth Bankert.

Slides:

Advertisements

Similar presentations

Office for Human Research Protections 1 Updating the Common Rule Governing Human Subjects Research Protections Jerry Menikoff.

Advertisements

FDA Research: Clearance Requirements and Implications Steven L. Bradbard, Ph.D. Team Leader, Consumer Studies CFSAN/ORPSS.

The Institutional Review Board. What is an IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.

TEXAS SOUTHERN UNIVERSITY OFFICE OF RESEARCH LINDA M. GARDINER, Ph.D. DIRECTOR DEPARTMENT OF RESEARCH ENHANCEMENT AND COMPLIANCE SERVICES.

Subcommittee on Harmonization Mark Barnes David Forster.

Institutional Review Board Guidance.  Independent Ethics Committee  Ethical Review Board  Research Ethics Committee 2.

Proposed Changes to Common Rule Karen Allen Director, Research Protections Office of Research Administration August

IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.

Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.

CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.

IRB-Investigator/ Research Coordinator Mtg. “What You Can Do to Facilitate an Efficient IRB Review” January 13, 2004 George Gasparis.

IRB Basics Helen Panageas New York University School of Medicine Institutional Review Board Portion of slides courtesy of Suzanne M. Smith, University.

Safety and Loss Control

Educational Research and the VCOM Institutional Review Board

Copyright © 2013 AAHRPP ® All rights reserved Elyse I. Summers, J.D. President and CEO CAREB 2015 National Conference Vancouver, British Columbia May 1-2,

KEYS TO SUCCESS NCURA Region IV Spring Meeting April 27 – 30, 2014 © 2014 National Council of University Research Administrators National Council of University.

2012 Hired Highway Safety Services to assist in the management of SMSA Opened the SMSA Business Office Created a new Web Page Distributed the SMSA Newsletter.

 Understanding the IRB Process University of Tennessee Health Science Center Institutional Review Board.

Comments from the Perspective of a Human Research Protections Program that Maximizes Opportunities to be Flexible and Innovative Lois Brako Assistant Vice.

Primary Care and Community Outreach Research VCOM Institutional Review Board Jim Mahaney, PhD Associate Dean for Biomedical Affairs, Virginia Campus Past.

Laura M. Argys Associate Dean for Research and Creative Activities College of Liberal Arts and Sciences University of Colorado Denver.

Secretary’s Advisory Committee on Human Subjects Protections (SACHRP) Summary of Responses on: Advanced Notice of Proposed Rulemaking (ANPRM) on Holding.

The Human Subjects Institutional Review Board Workshop Part 1: An Introduction to Human Subjects Research Ethics and the IRB Process Presented by Alena.

Yale Center for Clinical Investigation: Academic Home to the CTSA Secretary’s Advisory Committee on Human Research Protections (SACHRP) Presentation Tesheia.

Common Rule and FDA Regulation Comparison David Forster Jeff Cooper Gary Chadwick.

Research Compliance: An Overview of the Players and Issues Involved in Emory’s Research Compliance Programs.

Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators Advanced Notice.

Aligning IRBs and the Ethical Conduct of Research APS Annual Convention, May 2008 Felice J. Levine American Educational Research Association American Educational.

Ethical Challenge & Solution in Social Behavioral Research Melody Lin December 2012.

Investigators’ Responsibilities in Conducting Human Subjects Research Dept. of Regulatory Affairs April 18, 2012.

CCAS Annual Conference: New Orleans, LA November 11, 2010 The Role of Deans: Regulatory & Administrative Responsibilities Michelle Feige, MSW Public Health.

Governance Subcommittee James Dobbins, Chair. Dobbins – Governance 13 December 2010 The Summary Mission Statement Foster engagement between the U.S. society.

Status of SACHRP Recommendations July 2003-October 2008 Meeting of the Secretary’s Advisory Committee on Human Research Protections October 27, 2008 Michael.

Community Based Participatory Research: Considerations for IRBs Puneet Chawla Sahota, Ph.D. Post-doctoral Fellow, National Congress of American Indians.

Institutional Review Board Issues for Classroom Research Sharon McWhorter IRB Administrator, The University of Akron (With assistance from Phil Allen,

OHRP Guidance and Policy Development Process Secretary’s Advisory Committee on Human Research Protections Meeting October 27, 2008 Irene Stith-Coleman,

Welcome New IRB Members! Today we will discuss: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.

OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.

Agenda for Session Compliance in Clinical Research

AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)

Fire and Devolution -a chance to act- Brian Robinson C.B.E. Q.F.S.M. Chairman, Fire Sector Federation.

Updates in Research Protections Karen Allen Director, Research Protections Office of Research November

Joni Barnard IRB Information Session: EHE Workshop 10/13/2015.

Welcome New IRB Member! This brief presentation covers: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.

Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.

EXPEDITED PROTOCOL REVIEW AN IRB INFOSHORT APRIL 2013.

© 2015 Marketo, Inc. Marketo Proprietary and Confidential Page 1 Investigators’ Responsibilities in Conducting Human Subjects Research Office of the Vice.

Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of.

Medical Research in Times of Bioterrorism - OHRP’s Perspective Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.

Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.

Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.

THE INSTITUTIONAL REVIEW BOARD. WHAT IS AN IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.

Protecting Human Subjects Overview of the Issues Applications to Educational Research The IRB Process.

Christine Yalda, J.D., Ph.D. Chair, Human Research Review Committee Grand Valley State University.

Building a Public Health Informatics Division. OSDH Public Health Informatics Division Identify the needs Develop the proposal Establish division Reality.

Updating the Common Rule Governing Human Subjects Research Protections

Governance Subcommittee

Beverley Alberola, CIP Associate Director, Research Protections

Overview - Introduction

Welcome New IRB Members!

Updates to Expedited Review Procedures

Updates to Expedited Review Procedures

Overview - Introduction

HUMAN RESEARCH PROTECTION PROGRAM or

Overview - Introduction

Updates to Expedited Review Procedures

George Alter ICPSR Institute for Social Research

Everything You Wanted to Know about UOPX IRB

IRB submissions for researchers

Presentation transcript:

a. Short term problems / considerations b. Long term mission View of human subjects protection system: SACHRP July 2008 Elizabeth Bankert

Problems 1. Relationship / communication / respect IRBs and researchers do not have a relationship based on mutual respect. IRBs are viewed by researchers as bureaucratic; overly focused on regulatory documentation; and do not provide useful review comments. Researchers are viewed by IRB administrators as not well versed in regulations and/or not concerned enough about human subjects. OHRP is viewed as compliance driven and IRBs are ‘fearful’ of contacting OHRP for advice. OHRP and the FDA do not appear to work together on important issues of human research protections. There has been no ‘proof’ that increased regulatory burden has improved human subjects research review system.

a. Minimal risk research review is burdensome to IRBs and researchers. Minimal risk review diverts valuable time and resources from Full Committee reviews and time to devote to ‘big picture’ issues. b.Multi-site review is redundant, inconsistent, and does not necessarily enhance overall review quality. Problems (continued) Review processes:

OHRP leadership and staff should shift ‘perceived’ focus away from regulatory documentation and from being compliance driven to: - Educate IRBs on review of minimal risk research; review should be efficient, effective, and focused on issues not on documentation. Exempt is OK. Expedited is OK ( though change of terminology may be useful). - Develop ‘best practice forms’, application, minutes, agenda. - Encourage trust between IRBs in multi-site research. “IRB networking“: retain local review but become aware of other IRB reviews. Consider:

The Office for Human Research Protections (OHRP) supports, strengthens and provides leadership to the nation’s system for protecting volunteers in research that is conducted or supported by the U.S. Department of Health and Human Services (HHS). OHRP provides clarification and guidance to research institutions, develops educational programs and materials, and promotes innovative approaches to enhancing human subject protections. From OHRP website – Fact Sheet: Long term mission

Mission (reinvented): OHRP’s priorities should shift (from compliance driven) to becoming a proactive, collective voice for IRBs and researchers in order to improve the system Encourage and organize national dialogs related to all human subjects research issues. Include FDA, federal funding agencies, IRBs, and researchers. Actively announce actions to promote building of trust in the research enterprise.

How ? Considerations : 1. SACHRP 2. OHRP leadership / staff shift focus 3. OHRP dialog with IRBs and researchers 4. OHRP dialog with FDA